C3 glomerulopathy: advancements in diagnostics and therapeutics
The new diagnostic, genetic, and molecular developments are discussed; changes in nomenclature and taxonomy are reviewed. Finally, landmark trials (such as the APPEAR-C3G and VALIANT, respectively) are reviewed to provide clinicians and clinician researchers with a timely update of new events in C3G.
Authors
- Annemarie van der Ham
- Rebecca S. Ahdoot
- Surjit B. Dixit (ORCID: https://orcid.org/0000-0003-0197-1629)
- Ramy Magdy Hanna (ORCID: https://orcid.org/0000-0003-1807-8909)
- Yongen Chang
Institutions
- University of California, Irvine (US)
- Irvine University (US)
Publication Details
- Journal
- Current Opinion in Nephrology & Hypertension
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/mnh.0000000000001133
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00